265643-72-9

Upstream product

• 265643-71-8 toluene-4-sulfonic acid 5-hydroxymethyl-1H-pyrazol-3-yl ester 
• 446-24-2 2-fluorobezohydrazide 
• 98-59-9 p-toluenesulfonyl chloride 
• 265643-74-1 toluene-4-sulfonic acid 5-[(2-fluoro-benzoyl)-hydrazonomethyl]-1H-pyrazol-3-yl ester 
• 265643-73-0 toluene-4-sulfonic acid 5-formyl-1H-pyrazol-3-yl ester 

Downstream Products

• 265642-78-2 3-bromo-7-(2-fluorophenyl)-2-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)pyrazolo[1,5-d][1,2,4]triazine 
• 265643-76-3 3-bromo-7-(2-fluorophenyl)pyrazolo[1,5-d][1,2,4]triazin-2-ol 
• 265643-75-2 7-(2-fluorophenyl)pyrazolo[1,5-d][1,2,4]triazin-2-ol 

Relevant academic research and scientific papers

2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: Functionally selective GABAA α3-subtype agonists

Novel synthetic routes have been devised for the preparation of previously inaccessible 2,3,7-trisubstituted pyrazolo[1,5-d][1,2,4]triazines 2. These compounds are high affinity ligands for the GABAA benzodiazepine binding site and some analogu

Pyrazolo-triazine derivatives as ligands for GABA receptors

Compounds according to Formula (I): or a salt or prodrug thereof, have good affinity as ligands for the alpha2 and/or alpha3 subunit of the human GABAAreceptor and are useful for treatment of disorders of the central nervous system, including a